Phenytoin Correction Calculator

Correct total phenytoin level for hypoalbuminemia.

Created by Luis GonzalezLast updated: May 9, 2026

How to Use This Calculator

1
Enter Measured Phenytoin Level
Input the total phenytoin concentration (in mcg/mL) obtained from the laboratory test.
2
Enter Albumin Level
Input the patient's serum albumin concentration (in g/dL). This is crucial for correcting phenytoin levels.
3
Review Your Results
Examine the corrected phenytoin level to guide appropriate dosing and therapeutic management.

Example Calculation

A pharmacist adjusts phenytoin dosing for a patient with low albumin levels to ensure therapeutic efficacy.

Measured Phenytoin

Albumin

2.5

Results

17.78 mcg/mL

Tips

Verify Laboratory Albumin Reference Ranges

While a normal albumin range is typically 3.5-5.0 g/dL, always confirm the specific reference range used by your laboratory. Hypoalbuminemia (albumin < 3.5 g/dL) is the primary indicator for needing phenytoin correction.

Consider Renal Function for Formula Selection

Different correction formulas exist, with some (like the Winter's equation) being more appropriate for patients with normal renal function, while others are adjusted for renal failure. Ensure you are applying the clinically relevant formula for the patient's kidney status.

Monitor for Clinical Signs of Toxicity

Despite correction, always correlate calculated levels with clinical signs and symptoms. Phenytoin toxicity can manifest as nystagmus (typically >20 mcg/mL), ataxia (>30 mcg/mL), or lethargy (>40 mcg/mL), even if corrected levels appear therapeutic.

Precisely Adjusting Phenytoin Dosing with Albumin Correction

The Phenytoin Correction Calculator is a critical tool for pharmacists and healthcare providers, designed to adjust measured total phenytoin levels in patients with hypoalbuminemia. Phenytoin is a narrow therapeutic index drug, meaning small changes in concentration can lead to significant clinical effects. This calculator addresses a common challenge in pharmacotherapy by providing a corrected phenytoin level, offering a more accurate estimate of the active drug concentration and aiding in precise dosing decisions to prevent both toxicity and sub-therapeutic outcomes.

Why Albumin Levels Impact Phenytoin Efficacy

Albumin levels significantly impact the efficacy and safety of phenytoin because the drug is highly protein-bound, with approximately 90% typically binding to albumin in the bloodstream. Only the unbound or "free" fraction of phenytoin is pharmacologically active and capable of exerting its anticonvulsant effects. In patients with hypoalbuminemia (low albumin levels, typically below 3.5 g/dL), there are fewer binding sites available. This results in a higher proportion of free phenytoin, even if the measured total phenytoin level appears within the normal therapeutic range (10-20 mcg/mL). Without correction, clinicians might mistakenly assume a patient is under-dosed, leading to increased doses and potentially toxic free phenytoin concentrations.

The Formula for Correcting Phenytoin Levels

The correction of phenytoin levels for hypoalbuminemia typically uses a formula that accounts for the patient's measured albumin concentration. One widely accepted formula, often referred to as Winter's formula, is particularly useful for patients with normal renal function.

The formula is:

Corrected Phenytoin (mcg/mL) = Measured Phenytoin / (0.2 + (0.1 × Albumin))

Measured Phenytoin: The total phenytoin concentration reported by the lab (mcg/mL).
Albumin: The patient's serum albumin concentration (g/dL).

This formula mathematically estimates what the total phenytoin level would be if the patient had a normal albumin level, thus providing a better proxy for the active, unbound drug concentration.

💡 For medications that are highly protein-bound, like phenytoin, accurate albumin correction is essential. Our Albumin-Corrected Drug Level Calculator offers a direct way to compute adjusted drug levels for various medications.

Calculating Corrected Phenytoin for a Hypoalbuminemic Patient

Consider a patient whose measured total phenytoin level is 8 mcg/mL. However, the patient's serum albumin level is low at 2.5 g/dL, indicating hypoalbuminemia. A healthcare provider needs to determine the corrected phenytoin level to ensure safe and effective anticonvulsant therapy.

Here's the step-by-step calculation:

Identify Inputs:
- Measured Phenytoin: 8 mcg/mL
- Albumin: 2.5 g/dL
Apply the Correction Formula:
- Corrected Phenytoin = 8 / (0.2 + (0.1 × 2.5))
- Corrected Phenytoin = 8 / (0.2 + 0.25)
- Corrected Phenytoin = 8 / 0.45
- Corrected Phenytoin ≈ 17.78 mcg/mL

Despite the measured total phenytoin being 8 mcg/mL (which is sub-therapeutic), the corrected phenytoin level is approximately 17.78 mcg/mL. This indicates that the patient's active drug concentration is within the therapeutic range (10-20 mcg/mL), and no dose increase is immediately warranted, preventing potential toxicity.

💡 For drug dosing in specific patient populations, especially those with altered body composition, our Adjusted Body Weight Calculator can help tailor dosages for improved safety and efficacy.

Clinical Significance of Phenytoin Levels and Albumin

In clinical practice, the therapeutic range for total phenytoin is typically 10-20 mcg/mL, but this range is only reliable when albumin levels are normal (3.5-5.0 g/dL). Phenytoin's narrow therapeutic index means that levels just above 20 mcg/mL can cause nystagmus, while levels exceeding 30 mcg/mL can lead to ataxia and mental status changes, and levels over 40 mcg/mL can be life-threatening. When a patient has hypoalbuminemia (e.g., 2.5 g/dL), the measured total phenytoin may appear low, but the concentration of the active, unbound drug could be much higher, potentially leading to toxicity. Therefore, correcting for albumin is a crucial step to accurately assess the patient's true therapeutic status and adjust dosing appropriately.

Guidelines for Phenytoin Monitoring and Correction

The practice of correcting phenytoin levels for hypoalbuminemia is a well-established clinical standard, guided by various professional pharmacy and neurology associations. For instance, the American Society of Health-System Pharmacists (ASHP) and other clinical pharmacology guidelines recommend using a corrected phenytoin formula when a patient's serum albumin concentration falls below 3.5 g/dL. This ensures that dosing decisions are based on an accurate estimation of the free (active) drug concentration, especially in vulnerable populations such as critically ill patients, those with renal failure, or those with significant liver dysfunction. Adherence to these guidelines helps prevent both sub-therapeutic treatment and phenytoin toxicity, which can have severe neurological consequences.

Frequently Asked Questions

Why is phenytoin level corrected for albumin?

Phenytoin is highly protein-bound, primarily to albumin, meaning only the unbound or 'free' drug is pharmacologically active. When albumin levels are low (hypoalbuminemia), a larger fraction of phenytoin remains unbound. Correcting the total phenytoin level for albumin provides a more accurate estimate of the active free drug concentration, which is essential for guiding dosing and preventing toxicity or sub-therapeutic effects.

What is the therapeutic range for total phenytoin?

The generally accepted therapeutic range for total phenytoin in most patients is 10 to 20 mcg/mL. However, for patients with hypoalbuminemia or renal impairment, this range may not accurately reflect the free drug concentration. In such cases, the corrected phenytoin level aims to approximate what the total level would be if albumin were normal, ensuring effective and safe treatment.

When should phenytoin correction not be used?

Phenytoin correction for albumin is typically not necessary when albumin levels are within the normal range (e.g., 3.5-5.0 g/dL), as the protein binding is stable. Additionally, if free phenytoin levels are directly measured, correction formulas are not needed, as the free level inherently reflects the active drug concentration. Always consult clinical guidelines for specific patient populations.

What are common causes of hypoalbuminemia?

Hypoalbuminemia, or low serum albumin, can be caused by various clinical conditions that alter albumin synthesis, distribution, or catabolism. Common causes include chronic liver disease (impaired synthesis), malnutrition, severe burns (increased loss), nephrotic syndrome (renal loss), and critical illness or inflammation (capillary leak and altered distribution). These conditions necessitate phenytoin correction.